These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12883976)

  • 1. Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever.
    Işlek I; Simşek T; Baskin E; Simşek B; Küçüködük S; Bedir A; Bakkaloğlu A; Beşbaş N; Topaloğlu R; Ozen S; Saatçi U
    Pediatr Nephrol; 2003 Oct; 18(10):1005-8. PubMed ID: 12883976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
    Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
    Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia.
    Han Z; Heath SC; Shmulewitz D; Li W; Auerbach SB; Blundell ML; Lehner T; Ott J; Stoffel M; Friedman JM; Breslow JL
    Am J Med Genet; 2002 Jul; 110(3):234-42. PubMed ID: 12116231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein AI and apolipoprotein B containing particle analysis in normolipidemic hemodialyzed patients: evidence of free apolipoprotein E.
    Kandoussi AM; Hugue V; Parra HJ; Dracon M; Fruchart JC; Tacquet A; Cachera C
    Am J Nephrol; 1996; 16(4):287-92. PubMed ID: 8739280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fasting.
    Adlouni A; Ghalim N; Saïle R; Hda N; Parra HJ; Benslimane A
    Clin Chim Acta; 1998 Mar; 271(2):179-89. PubMed ID: 9565333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients.
    Deveci K; Gokakin AK; Senel S; Deveci H; Uslu AU; Sancakdar E
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):253-60. PubMed ID: 23377817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
    Bozaci I; Tatar E
    Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.
    Yilmaz H; Inan O; Darcin T; Bilgic MA; Akcay A
    Clin Exp Nephrol; 2015 Jun; 19(3):436-42. PubMed ID: 25059227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Turk J Pediatr; 1992; 34(1):15-20. PubMed ID: 1509525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of apolipoprotein AI, AII, and E in plasma and lipoprotein fractions of alcoholic patients: gender differences in the effects of alcohol.
    Lin RC; Miller BA; Kelly TJ
    Hepatology; 1995 Apr; 21(4):942-9. PubMed ID: 7705804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary glycosaminoglycans in the course of familial Mediterranean fever.
    Baskin E; Saatçi U; Ciliv G; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S
    Eur J Pediatr; 2003 May; 162(5):305-8. PubMed ID: 12692710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum apolipoprotein AII/AI ratio in systemic amyloidosis.
    Yamada T; Ozawa T; Gejyo F; Okuda Y; Takasugi K; Hotta O; Itoh Y
    Ann Rheum Dis; 1998 Apr; 57(4):249-51. PubMed ID: 9709183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apolipoprotein levels in preeclamptic pregnancies].
    Kobayashi S; Tanaka M; Masaki K; Hirakawa S; Momose K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):223-8. PubMed ID: 1545175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood lipids in renal amyloidosis].
    Srinivas KV; Neverov NI; Kolonduk NV; Tambovtseva EV; Kozlova RI
    Urol Nefrol (Mosk); 1993; (1):28-31. PubMed ID: 7941122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrotic syndrome as a first manifestation of familial Mediterranean fever].
    Gingold-Belfer R; Bergman M; Ori Y; Salman H
    Harefuah; 2006 Oct; 145(10):706-8, 784. PubMed ID: 17111701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review.
    Erer B; Demirkaya E; Ozen S; Kallinich T
    Rheumatol Int; 2016 Apr; 36(4):483-7. PubMed ID: 26712372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
    Sante; 2004; 14(4):261-6. PubMed ID: 15745878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
    Serelis J; Christaki S; Skopouli FN
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S169. PubMed ID: 25572486
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
    J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary amyloidosis in familial Mediterranean fever.
    Sahan C; Cengiz K
    Acta Clin Belg; 2006; 61(3):147-51. PubMed ID: 16881565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.